Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Profit After Tax: 2020-2023

Historic Profit After Tax for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$53.5 million.

  • Immuneering's Profit After Tax fell 13.88% to -$15.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$53.5 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of -$53.5 million for FY2023, which is 5.86% down from last year.
  • Per Immuneering's latest filing, its Profit After Tax stood at -$53.5 million for FY2023, which was down 5.86% from -$50.5 million recorded in FY2022.
  • In the past 5 years, Immuneering's Profit After Tax registered a high of -$17.0 million during FY2020, and its lowest value of -$53.5 million during FY2023.
  • Its 3-year average for Profit After Tax is -$45.8 million, with a median of -$50.5 million in 2022.
  • Data for Immuneering's Profit After Tax shows a maximum YoY tumbled of 96.81% (in 2021) over the last 5 years.
  • Over the past 4 years, Immuneering's Profit After Tax (Yearly) stood at -$17.0 million in 2020, then plummeted by 96.81% to -$33.5 million in 2021, then plummeted by 50.63% to -$50.5 million in 2022, then fell by 5.86% to -$53.5 million in 2023.